Background In previous meta-analyses, tea consumption has been associated with lower incidence of type 2 diabetes. It is unclear, however, if tea is associated inversely over the entire range of intake. Therefore, we investigated the association between tea consumption and incidence of type 2 diabetes in a European population. Methodology/Principal Findings The EPIC-InterAct case-cohort study was conducted in 26 centers in 8 European countries and consists of a total of 12,403 incident type 2 diabetes cases and a stratified subcohort of 16,835 individuals from a total cohort of 340,234 participants with 3.99 million person-years of follow-up. Country-specific Hazard Ratios (HR) for incidence of type 2 diabetes were obtained after adjustment for lifestyle and dietary factors using a Cox regression adapted for a case-cohort design. Subsequently, country-specific HR were combined using a random effects meta-analysis. Tea consumption was studied as categorical variable (0, >0-<1, 1-<4, ≥4 cups/day). The dose-response of the association was further explored by restricted cubic spline regression. Country specific medians of tea consumption ranged from 0 cups/day in Spain to 4 cups/day in United Kingdom. Tea consumption was associated inversely with incidence of type 2 diabetes; the HR was 0.84 [95%CI 0.71, 1.00] when participants who drank ≥4 cups of tea per day were compared with non-drinkers (p linear trend = 0.04). Incidence of type 2 diabetes already tended to be lower with tea consumption of 1-<4 cups/day (HR = 0.93 [95%CI 0.81, 1.05]). Spline regression did not suggest a non-linear association (pnon-linearity = 0.20). Conclusions/Significance A linear inverse association was observed between tea consumption and incidence of type 2 diabetes. People who drink at least 4 cups of tea per day may have a 16% lower risk of developing type 2 diabetes than non-tea drinkers.
Tea Consumption and Incidence of Type 2 Diabetes in Europe: The EPIC-InterAct Case-Cohort Study
Geertruida J. van Woudenbergh,A. Kuijsten,D. Drogan,D. van der A,D. Romaguera,E. Ardanaz,P. Amiano,A. Barricarte,J. Beulens,H. Boeing,H. Bueno-de-Mesquita,C. Dahm,M. Chirlaque,F. Clavel,F. Crowe,P. Eomois,G. Fagherazzi,P. Franks,J. Halkjaer,K. Khaw,G. Masala,A. Mattiello,P. Nilsson,K. Overvad,J. Ramón Quirós,O. Rolandsson,I. Romieu,C. Sacerdote,María-José Sánchez,M. Schulze,N. Slimani,I. Sluijs,A. Spijkerman,G. Tagliabue,A. Tjønneland,R. Tumino,N. Forouhi,S. Sharp,C. Langenberg,E. Feskens,E. Riboli,N. Wareham
Published 2012 in PLoS ONE
ABSTRACT
PUBLICATION RECORD
- Publication year
2012
- Venue
PLoS ONE
- Publication date
2012-05-30
- Fields of study
Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-36 of 36 references · Page 1 of 1
CITED BY
Showing 1-79 of 79 citing papers · Page 1 of 1